ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,956Medicare Part D Prescriptions Filled, Including Refills

Rank: 56 out of 113

$380K Total Retail Price of All Prescriptions

Rank: 56 out of 113

352 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 352 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 352 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 5,986 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
SIMVASTATIN 369 357 1 2
LEVOTHYROXINE SODIUM 321 319 2 1
POTASSIUM CHLORIDE 224 202 3 12
METOPROLOL SUCCINATE 212 206 4 10
WARFARIN SODIUM 212 209 4 8
FUROSEMIDE 184 163 6 6
HYDROCODONE-ACETAMINOPHEN 173 108 S3 7 7
AMLODIPINE BESYLATE 169 160 8 4
OMEPRAZOLE 165 150 9 5
LISINOPRIL 155 133 10 3
TAMSULOSIN HCL 113 104 11 24
METOPROLOL TARTRATE 109 97 12 14
ZOLPIDEM TARTRATE 102 94 13 19
METFORMIN HCL 96 79 14 11
ATENOLOL 95 91 15 16
ALLOPURINOL 94 94 16 20
LOSARTAN POTASSIUM 89 88 17 13
GABAPENTIN 84 67 18 18
PANTOPRAZOLE SODIUM 82 65 19 52
OXYCODONE HCL 78 34 S2 20 62
TRIAMTERENE-HYDROCHLOROTHIAZID 77 60 21 91
ATORVASTATIN CALCIUM 77 72 21 15
TERAZOSIN HCL 76 73 23 106
CITALOPRAM HBR 68 42 24 17
CYMBALTA 67 47 25 37
HYDROCHLOROTHIAZIDE 66 60 26 9
TRAMADOL HCL 63 50 27 29
PAROXETINE HCL 62 59 28 45
TRIAMTERENE-HCTZ 59 50 29 26
TRAZODONE HCL 59 33 29 41
PRAVASTATIN SODIUM 56 51 31 23
SERTRALINE HCL 54 48 32 21
MELOXICAM 53 52 33 44
DONEPEZIL HCL 53 53 33 33
LYRICA 51 34 35 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 11, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.